Marta Sokolowska PhD
Associate Director for Control Substances
Marta Sokolowska, Ph.D., serves as Associate Director for Controlled Substances in the Center for Drug Evaluation and Research. She is a recognized expert in drug abuse potential assessment and scheduling strategies. Dr. Sokolowska has facilitated numerous initiatives to improve public health by advancing the science of assessing abuse liability. She joined FDA in December 2018 and oversees the Controlled Substance Staff (CSS). CSS provides consultation throughout FDA on evaluation of abuse potential of drugs and advises on all matters related to domestic and international drug scheduling.
Dr. Sokolowska earned her doctoral degree in psychology from McMaster University in Canada.